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Abstract 
 
Aim: To investigate differences between the early symptoms of schizophrenia and 
depressive disorders. 
 
Methods: Sixty-one individuals with an at-risk mental state (ARMS), 17 of whom later 
made the transition to psychosis (ARMS-T), 37 patients with a first episode of 
psychosis (FE) and 16 controls with depressive disorders (DC) were interviewed about 
first self-perceived signs and symptoms.  
 
Results: In ARMS and FE, on average, first self-perceived signs or symptoms had 
occurred about 5-6 years before the interview. 
In ARMS, including ARMS-T, "loss of energy" and "difficulties concentrating" were the 
most frequently recalled first signs. There was much overlap for the four most 
frequently mentioned symptoms in the three groups. 
As compared to ARMS, DC significantly more often recalled "depression" and "social 
isolation" as the very first signs of disease.  
 
Conclusions: Clinicians should consider the development of self-recalled first signs 
over time carefully when assessing suspected early prodromal stages of schizophrenia 
and beginning depressive disorder.  
 
Keywords: at risk mental state, depressive disorders, early recognition, psychotic 
disorders, schizophrenia. 
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 1.  Introduction 
 
The prodrome of schizophrenia is characterised by unspecific symptoms. 
Subjects concerned often realise something is “wrong”, years before diagnostic criteria 
for a psychotic disorder are met. The duration of the prodrome is variable, around 2 - 
3.5 years (1).  
  Self-perceived deficits concerning perception, cognition and stress reactivity 
have been reported in the prodrome, negative symptoms and depression are also 
often present (2-6).  
Depressive symptoms are often so severe that depression is reported as a comorbid 
diagnosis (7-9). This indicates an overlap between symptoms of depressive disorders 
and beginning psychosis, which makes differential diagnosis, especially in early 
phases, difficult.  
There are few studies comparing the earliest phase of the prodrome in 
schizophrenia with depressive disorders. Using a retrospective interview in patients 
with a first episode of psychosis (FE) and patients with depression, Häfner et al. 
compared the presenting initial symptoms in psychosis and major depression. A high 
degree of overlap in the ten most frequent presenting symptoms was found (10).  
 The aim of this study is to clarify which early signs may be useful for 
differentiating an early prodromal stage of psychosis from depression. At-risk mental 
state (ARMS) individuals, with a focus on the subgroup with later transition to 
psychosis (ARMS-T), that is with a confirmed prodrome, were compared with patients 
with depressive disorders (DC) and FE. 
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2. Methods 
2.1. Subjects 
From 3/1/2000 – 29/2/2004 we screened 234 individuals referred to our 
specialised outpatient clinic for the early recognition of psychosis as they were 
suspected to be at risk for or in an early stage of psychosis. The screening was 
conducted within the FePsy (Früherkennung von Psychosen – early detection of 
psychosis) study (11), using the Basel Screening Instrument for Psychosis (BSIP) (12), 
which allows to identify ARMS and FE individuals according to the criteria of Yung et 
al. (13).  
In 38 cases no risk for psychosis was found. One hundred and six were 
identified as ARMS, 42 refused participation, 64 agreed to participate in the main 
study, 61 of these could be interviewed with the Basel Interview for Psychosis (see 
below). Of these 61 ARMS, n=50 could be followed up until 3/1/2007 and 17 made the 
transition to psychosis.  
 
Thirty-seven of the screened FE from our specialised outpatient clinic were also 
interviewed, these patients were either still in or recovering from a first psychotic 
episode.  
The other control group consisted of 16 patients with depressive disorders (DC-
15: major depression, 1: adjustment disorder/depressive reaction DSM-IV), these were 
outpatients from our general outpatient clinic remitting from a depressive episode, they 
had not been referred with suspected psychosis.  
All study subjects gave written informed consent and the study was approved by the 
Ethics Committee of Basel, Switzerland. 
Exclusion criteria were age below 18 years, insufficient knowledge of German, 
IQ <70, psychosis clearly due to organic reasons or substance abuse, or psychotic 
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symptoms within a clearly diagnosed depressive disorder oder borderline personality 
disorder (11, 14). 
 
 
 
2.2. Interview 
The Basel Interview for Psychosis is a structured interview covering all aspects 
of the patient's history which contribute to assessing the risk for psychosis. It was 
specifically developed for the Basel FePsy study (11). All important risk factors and 
early signs of psychosis, such as prodromal symptoms, overall loss in general 
functioning, beginning "subthreshold" psychotic symptoms, genetic and other risk 
factors, drug abuse early indicators such as childhood developmental disturbances, 
etc. were included. Also already established instruments such as the IRAOS 
(Instrument for the Retrospective Assessment of Schizophrenia (15)), the SIPS/SOPS 
(Structured Interview for Prodromal Syndromes/Scale of Prodromal Syndromes (16)), 
and the BSABS (Bonn Scale for the Assessment of Basic Symptoms (17)) were taken 
into account.  
One section explores when any change in well-being was first noticed and what 
the very first signs and symptoms were; up to three can be mentioned in response to 
an open question, and, for this analysis, were then categorised post-hoc.  
All interviews were conducted by experienced psychiatrists, after a series of 
training sessions. 
For diagnostic purposes the SCID (Structured Clinical Interview for DSM 
Disorders) was performed at baseline (18-20). 
 
2.3. Statistical Analyses 
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Statistical analyses were performed with the Statistical Package for the Social 
Sciences (SPSS 14.0). Sociodemographic differences between groups were examined 
using the chi-square test, and ANOVA for age. For every symptom, the chi-square test 
was used for overall group comparison (ARMS/FE/DC) and post hoc for items where a 
significant difference was found. In an additional analysis, differences between ARMS-
T and DC were evaluated with the chi-square test. 
 
3. Results 
3.1. Sample Characteristics 
The mean age of the 61 ARMS (36 male, 25 female) was 26.6 years (SD 8.5 
years), of the 37 FE (25 male, 12 female) 31.1 years (SD 8.5 years) and of the 16 DC 
(8 male, 8 female) 27.3 years (SD 5.6 years). The significant difference in mean age 
between groups (F=3.7, df=2, p=0.026) was only due to the higher age of FE 
compared to ARMS. There were no significant differences between groups for gender 
distribution (chi square=1.56, df=2, p=0.457) or educational level (chi square=6.82, 
df=6, p=0.338).  
 
3.2. Duration of Symptoms  
On average, first self-perceived signs or symptoms had occurred about 5-6 
years before the interview which was conducted at baseline, at the time of the first 
contact with our specialised clinic. Mean duration from the very first signs up to the 
interview was 60.6 (SD 63.9) months for ARMS and 70.5 (SD 86.5) months for FE. 
The median was 48 months for ARMS and 36 months for FE. 
 
3.3. First Signs and Symptoms 
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Table 1 shows the most frequently mentioned first signs and symptoms of 
ARMS, FE, and DC ranked by frequencies within each group. 
"Loss of energy" and "difficulties concentrating" were the most frequently mentioned 
first signs in ARMS, "depression" and "irritability" the most frequent in FE, and 
"depression" and "social isolation" the most frequent in DC.  
   
Table 1  
 
3.4. SCID-results 
A SCID-interview was done at baseline in 68.8% of the ARMS. In 34.1% of 
these a mood disorder was found, and in 6.8% anxiety disorder. 
 
3.5. Group Comparison 
There was much overlap in the first self-percieved signs of illness – 
“depression”, “irritability”, and “social isolation” being mentioned often. In the overall 
group comparison (ARMS/FE/DC), only two significant differences were found: 
"depression" and "social isolation" (see Fig 1). In the post hoc analysis for the item 
"depression", significant differences were found between ARMS and DC, for "social 
isolation" also between ARMS and DC, as well as between FE and DC. 
 
Figure 1  
 
3.6. Subgroup of ARMS-T 
We separately analysed those 17 ARMS who went on to develop psychosis 
(ARMS-T). The two most frequently mentioned first signs also were "loss of energy" 
(17.6%) and "difficulties concentrating" (17.6%). Also, the overall pattern of first signs 
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and symptoms was similar to the total ARMS sample: beginning difficulties at school, 
unusual fears and suspiciousness were frequently reported. 
The comparison of 17 ARMS-T with DC again showed significant differences for 
"depression" (p=0.031) and "social isolation" (p=0.021).  
 
 
4. Discussion 
There was much overlap in the very first signs over all groups, “depression” 
(meaning “feeling sad”, and not having a clinical diagnosis of depression in this 
context), “irritability”, and “social isolation” are all mentioned amongst the first four 
signs in each group. The percentage of ARMS individuals with a SCID-diagnosis of 
mood disorder was, as to be expected, relatively high. 
Häfner et al. 1999 reported on the first 10 most frequent earliest signs of 
schizophrenia, depressive mood emerged before the first positive symptom in about 
42% of the patients, and was amongst the first 10 most frequent reported very first 
signs. 
ARMS individuals mainly described "loss of energy" and "difficulties 
concentrating" as very first signs. Restricting the analyses to those who later made the 
transition to psychosis, the results remained stable. To our knowledge, this is the first 
study to investigate early signs and symptoms in ARMS individuals interviewed before 
the onset of psychosis, that is in a “true” prodromal stage, and perceived themselves 
when they first noticed a change in wellbeing, in comparison to DC. Although 14.8% of 
ARMS individuals also mentioned "depression" as one of the first three symptoms, DC 
significantly more often reported "depression" and "social isolation" as very first signs. 
 Interestingly, difficulties concentrating and loss of energy were not mentioned 
frequently by FE as very first signs, but they recalled feeling depressed, irritable, 
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worried, and socially isolated. Similar results were found in another study on FE 
patients retrospectively interviewed about the first signs of mental disease (21). The 
difficulties concentrating and loss of energy mentioned by the ARMS seem to be less 
important to the FE patients in retrospect and at this later stage. An explanation may 
be that subtle first signs pale after the experience of acute psychosis, and recall bias is 
more of a problem.  
Self-reported difficulties concentrating may be an indicator of neurocognitive 
deficits, which are known to be present in ARMS (14, 22, 23) and have also been 
reported in individuals with a genetic risk for schizophrenia (24). Specific cognitive 
deficits, combined with certain early symptoms in an integrated model, have been 
shown to improve prediction of transition to psychosis (14).  
The present study furthermore confirms the long delay between first symptoms and 
help-seeking which has also been found in other studies (for review Riecher-Rössler et 
al. (1); Barnes et al. (25); O’Callaghan et al. (26)).  
As the prodrome can be of long duration, when exploring very first signs of 
disease, there can be a problem of recall bias. This should be mentioned as a limiting 
factor. Another limiting factor is the moderate sample size, especially the controls with 
depression. 
 
Conclusion 
Clinicians should consider the development of self recalled first signs over time 
carefully when assessing a suspected early stage of schizophrenia and depressive 
disorders in young adults. 
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Table 1. First self-perceived signs1 of illness in ARMS, FE and DC – ranking order  
ARMS (n=61) FE (n=37) DC (n=16) 
1. loss of energy
 
18.0%
 
1. depression
 
24.3%
 
1. depression
 
43.8% 
2. difficulties 
concentrating
 
16.4%
 
2. irritability
 
13.5%
 
2. social isolation
 
37.5%
 
3. depression
 
14.8%
 
3. anxiety
 
10.8%
 
3. nervousness
 
18.8%
 
4. social isolation
 
14.8%
 
4. social isolation
 
10.8%
 
4. irritability
 
12.5%
 
5. sleep disturbance
 
11.5%
 
5. suspiciousness
 
8.1%
 
5. sleep disturbance
 
12.5%
 
6. over-sensitivity
 
11.5%
 
6. over-sensitivity
 
8.1%
 
6. abnormal 
appetite
 
12.5%
 
7. irritability
 
9.8%
 
7. nervousness
 
8.1%
 
   
8. unusual fears
 
8.2%
 
8. difficulties at 
work/school
 
8.1%
 
   
   
9. 
thoughts that 
others intend 
harm
 
8.1%
 
   
1Only signs occurring in more than 7% of the individuals are mentioned. 
 
ARMS: At Risk Mental State 
FE: First Episode of Psychosis 
DC: Controls with Depressive Disorder 
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Figure 1 
The most frequent first signs in ARMS compared to the frequencies of the respective signs in FE 
and DC. 
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Significant differences (chi-square test): 
*1p=0.041 
*2
 p=0.048 
 
ARMS: At Risk Mental State 
FE: First Episode of Psychosis 
DC: Controls with Depressive Disorder 
 
*1 
*2 
